Tech Company Financing Transactions

EyeGate Pharmaceuticals Funding Round

Private investors participated in a $969 thousand capital raise for EyeGate Pharmaceuticals. The funding round was announced by the company on 9/30/2013.

Transaction Overview

Announced On
9/30/2013
Transaction Type
Debt
Amount
$968,971
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
271 Waverley Oaks Rd. 108
Waltham, MA 02452
USA
Email Address
Not Recorded
Overview
EyeGate Pharma (NASDAQ: EYEG) is a late-stage specialty pharmaceutical and drug delivery company focused on developing and commercializing therapeutics and drug delivery mechanisms for treating diseases of the eye.
Profile
EyeGate Pharmaceuticals LinkedIn Company Profile
Social Media
EyeGate Pharmaceuticals Company Twitter Account
Company News
EyeGate Pharmaceuticals News
Facebook
EyeGate Pharmaceuticals on Facebook
YouTube
EyeGate Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Stephen From
  Stephen From LinkedIn Profile  Stephen From Twitter Account  Stephen From News  Stephen From on Facebook
Chief Financial Officer
Sarah Romano
  Sarah Romano LinkedIn Profile  Sarah Romano Twitter Account  Sarah Romano News  Sarah Romano on Facebook
VP - Engineering
Michael Manzo
  Michael Manzo LinkedIn Profile  Michael Manzo Twitter Account  Michael Manzo News  Michael Manzo on Facebook
VP - Operations
Lisa Brandano
  Lisa Brandano LinkedIn Profile  Lisa Brandano Twitter Account  Lisa Brandano News  Lisa Brandano on Facebook
VP - R & D
Brenda Mann
  Brenda Mann LinkedIn Profile  Brenda Mann Twitter Account  Brenda Mann News  Brenda Mann on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/30/2013: NaZura BioHealth venture capital transaction
Next: 9/30/2013: Proxy Debt Buyer venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary